Cure8 research brief
Biopsy-based keratin patterns might help distinguish IBD, microscopic colitis, and IBS—conditions that can look similar clinically—so this could improve diagnostic accuracy if validated.
Clinicians who diagnose and manage colitis (gastroenterologists, pathologists), researchers studying IBD biomarkers or epithelial biology, and patients interested in advances that could reduce diagnostic uncertainty between IBD, MC, and IBS.
Researchers stained archived colonic biopsy samples from two cohorts and used digital image analysis to quantify keratin staining. They report increased K8, K18, and K19 in UC (K18 also increased in CD), decreased K8 and K19 in MC, and keratin levels similar to controls in IBS.
In IBD, higher K8 and K19 associated with more severe epithelial damage and features of chronic injury; K7 correlated with K19 in IBD patients. The authors conclude that disease-specific keratin expression patterns have potential as diagnostic biomarkers to help separate IBD, MC, and IBS, but they state further validation is required.
This is a retrospective, tissue-based study using immunohistochemistry and image analysis (abstract-level summary). Reported associations do not establish causation or proven clinical utility; prospective validation is needed.
Review the original publication for the complete reporting, methods, and context.
Funding disclosed by the source: Tor, Joe, and Pentti Borg Memorial Fund; Satakunta Hospital District, Pori, Finland; Swedish Cultural Foundation; Satakunta Regional Fund of the Finnish Cultural Foundation; Academy of Finland, award 315139/332582; InFLAMES Flagship Programme, award 337531; Novo Nordisk Foundation, award NNF23OC0087039; Sigrid Juselius Foundation; ÅAU Center of Excellence of Cellular Mechanostasis
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Blood markers that correlate with endoscopic healing could help track inflammation noninvasively and may reduce the frequency of endoscopy if validated. For people with IBD, better blood-based tools could make monitoring...
Non-invasive urine biomarkers could make diagnosis and disease-activity monitoring easier and less invasive for people with IBD. Identifying metabolites linked to UC activity may help tailor monitoring without frequent...
A wearable sensor that reliably measures inflammation markers (CRP and calprotectin) from sweat could make inflammation monitoring less invasive and more frequent for people with IBD, potentially helping detect flares...
